News | December 20, 2023
Asahi Kasei opens new Bioprocess Technical Center in China
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Leading USA based genetic testing brand officially enters the Indian market
New facility is part of Aptar Pharma’s global expansion program
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The product has been in-licensed from Strides and will be commercialized by Amneal
The product is expected to be launched in FY25
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
